Skip to main content

Sol-Gel Technologies Ltd.

SLGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001684693

In the last 90 days, Sol-Gel Technologies Ltd. insiders filed 8 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $98.1M in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Sol-Gel Technologies Ltd. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
17
−1 vs. Q3 2024
Shares held
5.23M
−43.8K (−0.8%) vs. Q3 2024
Total value
$4.86M
+$1.28M (+35.6%) vs. Q3 2024
New holders
3
5 more added
Sold out
4
2 more reduced

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SLGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 17 institutions
Q1 2021: 20 institutionsQ2 2021: 16 institutionsQ3 2021: 18 institutionsQ4 2021: 18 institutionsQ1 2022: 17 institutionsQ2 2022: 17 institutionsQ3 2022: 13 institutionsQ4 2022: 14 institutionsQ1 2023: 15 institutionsQ2 2023: 17 institutionsQ3 2023: 18 institutionsQ4 2023: 21 institutionsQ1 2024: 20 institutionsQ2 2024: 20 institutionsQ3 2024: 20 institutionsQ4 2024: 17 institutionsQ1 2025: 21 institutionsQ2 2025: 11 institutionsQ3 2025: 10 institutionsQ4 2025: 14 institutionsQ1 2026: 21 institutionsQ2 2026: 24 institutions
Value heldQ4 2024: $4.86M
Q1 2021: $71.5MQ2 2021: $72.6MQ3 2021: $58.7MQ4 2021: $43.5MQ1 2022: $42.9MQ2 2022: $23.7MQ3 2022: $29.5MQ4 2022: $26.0MQ1 2023: $31.3MQ2 2023: $23.6MQ3 2023: $17.7MQ4 2023: $9.94MQ1 2024: $7.64MQ2 2024: $6.56MQ3 2024: $3.67MQ4 2024: $4.86MQ1 2025: $2.76MQ2 2025: $4.87MQ3 2025: $16.3MQ4 2025: $30.2MQ1 2026: $100.0MQ2 2026: $98.1M
Institutions holding SLGL and their total value by quarter
QuarterHoldersValue
Q2 202624$98.1M
Q1 202621$100.0M
Q4 202514$30.2M
Q3 202510$16.3M
Q2 202511$4.87M
Q1 202521$2.76M
Q4 202417$4.86M
Q3 202420$3.67M
Q2 202420$6.56M
Q1 202420$7.64M
Q4 202321$9.94M
Q3 202318$17.7M
Q2 202317$23.6M
Q1 202315$31.3M
Q4 202214$26.0M
Q3 202213$29.5M
Q2 202217$23.7M
Q1 202217$42.9M
Q4 202118$43.5M
Q3 202118$58.7M
Q2 202116$72.6M
Q1 202120$71.5M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Sol-Gel Technologies Ltd.; share changes are against Q3 2024.

Institutions holding SLGL in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Phoenix Holdings Ltd.2,470,192$2.30M0.03%00.0%Unchanged
Migdal Insurance & Financial Holdings Ltd.1,227,548$1.14M0.02%00.0%Unchanged
Harel Insurance Investments & Financial Services Ltd.920,333$856.0K0.01%00.0%Unchanged
Yelin Lapidot Holdings Management Ltd.227,078$211.2K0.04%−2,100−0.9%Reduced
Raymond James Financial Inc108,990$101.4K0.00%+108,990New
Morgan Stanley88,239$82.1K0.00%+54,879+164.5%Added
Menora Mivtachim Holdings Ltd.76,114$70.8K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA39,500$36.7K0.00%+1,800+4.8%Added
UBS Group AG21,258$19.8K0.00%+17,799+514.6%Added
Geode Capital Management, LLC13,406$12.5K0.00%00.0%Unchanged
Cetera Investment Advisers13,100$12.2K0.00%+2,600+24.8%Added
Virtu Financial LLC13,343$12.0K0.00%+13,343New
Steward Partners Investment Advisory, LLC5,160$4.80K0.00%+1,000+24.0%Added
BlackRock, Inc.3,089$2.87K0.00%00.0%Unchanged
Wells Fargo & Company500$4650.00%00.0%Unchanged
Bank of America Corp100$930.00%−2,311−95.9%Reduced
Simplex Trading, LLC27$00.00%+27New
Prosperity Wealth Management, Inc.0$00.00%−163,400−100.0%Sold out
Citadel Advisors LLC0$00.00%−39,629−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−25,887−100.0%Sold out
XTX Topco Ltd0$00.00%−10,922−100.0%Sold out
Raymond James Financial Services Advisors, Inc.––––Not filed
Raymond James & Associates––––Not filed